Does Pfizer's Latest News Snatch a Big Market Opportunity Away From Moderna?

·4-min read
Does Pfizer's Latest News Snatch a Big Market Opportunity Away From Moderna?

Pfizer (NYSE: PFE) just scored another first. The U.S. Food and Drug Administration (FDA) granted it authorization for the use of its coronavirus vaccine in a new age group -- 12 through 15. In December, Pfizer became the first company to win Emergency Use Authorization (EUA) for a coronavirus vaccine.